Re: Heng Li, Yucong Zhang, Dong Li, et al. Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Deprivation Therapy. Eur Urol 2021;79:879-86 AR-V7 is Rare in Hormone-sensitive Prostate Cancer: AR-V7 is Rare in Hormone-sensitive Prostate Cancer.

Sowalsky, Adam G; Plymate, Stephen R; Haffner, Michael C; de Bono, Johann S; Sharp, Adam

Sowalsky, Adam G; Plymate, Stephen R; Haffner, Michael C; de Bono, Johann S; Sharp, Adam.

Afiliação

Sowalsky AG; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: adam.sowalsky@nih.gov.
Plymate SR; University of Washington, Seattle, WA, USA; Geriatrics Research, Education and Clinical Center, VAPSHCS, Seattle, WA, USA.
Haffner MC; University of Washington, Seattle, WA, USA; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
de Bono JS; Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK.
Sharp A; Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK.

Eur Urol ; 82(5): e135-e136, 2022 11.

Article em En | MEDLINE | ID: mdl-36038450

Assuntos

Neoplasias de Próstata Resistentes à Castração; Receptores Androgênicos; Antagonistas de Androgênios/uso terapêutico; Androgênios; Humanos; Masculino; Feniltioidantoína; Neoplasias de Próstata Resistentes à Castração/patologia; Isoformas de Proteínas; Receptores Androgênicos/genética

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Prostata Base de dados: MEDLINE Assunto principal: Receptores Androgênicos / Neoplasias de Próstata Resistentes à Castração Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Eur Urol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google